-
公开(公告)号：KR1020130054518A
公开(公告)日：2013-05-27
申请号：KR1020110119926
申请日：2011-11-17
Applicant: 조선대학교산학협력단 , 광주대학교산학협력단
CPC classification number: A23L17/60 , A23L3/44 , A23V2002/00 , A23V2250/202 , A23V2300/14 , A61K36/04
Abstract: PURPOSE: A usage for health promoting food, a whitening cosmetic product, and a medicine using a seaweed methanol extract are provided to offer various biological activities including an antioxidant effect, a whitening effect, and an anti-inflammatory effect. CONSTITUTION: Porphyra yezoensis, Undaria pinnatifida, Hizikia fusiformis, Capsosiphon fulvescens, Enteromorpha Linza are collected. The seaweeds are washed and dried, then soaked in 500ml of 70% methanol for 100g of seaweeds before extracting for a week. The extract is filtered by using filtering paper. The filtered material is freeze-dried after the concentration by using an evaporator. [Reference numerals] (AA) Hizikia fusiformis; (BB) Porphyra yezoensis; (CC) Undaria pinnatifida; (DD) Enteromorpha Linza; (EE) Capsosiphon fulvescens
Abstract translation: 目的：提供健康促进食品，美白化妆品和使用海草甲醇提取物的药物的用途，以提供各种生物活性，包括抗氧化作用，美白效果和抗炎作用。 构成：收集紫菜，紫花苜蓿，烟丝，辣椒，枸杞子。 将海藻洗涤并干燥，然后在500ml 70％甲醇中浸泡100g海藻，然后提取一周。 萃取液用滤纸过滤。 通过使用蒸发器将过滤的物质在浓缩后冷冻干燥。 （AA）Hizikia fusiformis; （BB）紫菜紫菜; （CC）Undaria pinnatifida; （DD）Enteromorpha Linza; （EE）Capsosiphon fulvescens
-
-
公开(公告)号：KR101907275B1
公开(公告)日：2018-10-11
申请号：KR1020160173337
申请日：2016-12-19
Applicant: 광주대학교산학협력단
IPC: A23L33/10 , A23L33/135 , A23L33/105 , A23C9/123
Abstract: 본발명은황칠나무추출물을함유한유산균제품및 이의제조방법에관한것이다. 본발명에따른황칠나무추출물을함유한유산균제품은항산화효과, 지방축적억제효과, 항염증효과및 항고지혈증효과를발휘하며, 섭취에용이한형태로제조될수 있다.
-
公开(公告)号：KR101524401B1
公开(公告)日：2015-05-29
申请号：KR1020140003665
申请日：2014-01-11
Applicant: 광주대학교산학협력단
Abstract: 본발명은식물약재포재법에의한발효국을이용한고품질전통주의제조방법에관한것이다. 본발명은전통주의제조공정에있어서식물약재진액을포재법에의해기능성이강화된발효국을제공하고, 온도, 습도, 보쌈온도, 출국상태등을고려하여최적발효점을정량화함으로써생약재를이용한발효국생산기술을통해다양한전통주생산에활용가능한표준을제공할수 있다.
Abstract translation: 本发明涉及一种通过喷药草制造传统酒的方法。 根据本发明，当制造传统的液体时，提供具有通过喷洒药草而增强的功能的发酵曲; 通过考虑温度，湿度，用布包裹的温度和释放曲的条件来量化优化的发酵点。 因此，本发明可以提供从使用药草的曲曲生产技术获得的标准，并且可以应用于传统酒的生产。
-
公开(公告)号：KR1020170087819A
公开(公告)日：2017-07-31
申请号：KR1020160148504
申请日：2016-11-09
Applicant: 김현준 , 광주대학교산학협력단
Abstract: 본발명은체중증가용식품조성물에관한것으로, 분리대두단백, 결정과당분말, 카제인나트륨및 멀티비타민을포함하는상기식품조성물은부작용은없으면서체중및 근육량을증가시키는효능이있으므로, 저체중상태의소아, 청소년및 성인을위한체중증가용도로유용하게사용될수 있다.
Abstract translation: 本发明涉及用于增重的食物组合物，其中包含分离的大豆蛋白，果糖果糖粉，酪蛋白酸钠和多种维生素的食物组合物具有增加体重和肌肉量的作用而没有副作用， 对于青少年和成人的体重增加应用可能有用。
-
Patent Agency Ranking
公开(公告)号：KR1020170087791A
公开(公告)日：2017-07-31
申请号：KR1020160007818
申请日：2016-01-21
Applicant: 김현준 , 광주대학교산학협력단
Abstract: 해조류및 홍화씨추출물을포함하는성장촉진용식품조성물에관한것으로, 해조류및 홍화씨추출물은천연물유래의성분으로독성및 부작용은적으면서, 조골세포증식촉진효과가우수하므로성장촉진용식품조성물의유효성분으로유용하게사용될수 있다.
Abstract translation: 涉及生长促进含有藻类和红花提取物，藻类和红花种子提取物作为对飞毒性和副作用通常可用于促进生长的源自天然产物的食物的部件，所以具有优异的促进成骨细胞增殖的组合物的活性成分的食物组合物 可以有用地使用。
-
公开(公告)号：KR1020090093733A
公开(公告)日：2009-09-02
申请号：KR1020080043926
申请日：2008-05-13
Applicant: 조선대학교산학협력단
Abstract: A novel microorganism which produces a chemical having excellent antibacterial activity on methicillin-resistant Saphylococcus aureus (MRSA) is provided to enhance the efficiency of animal feed with high antibacterial activity and use as a feed additive. A Nocardia sp. CS682 (KCTC 11297BP) is isolated from soil. The Nocardia sp. CS682 (KCTC 11297BP) has 16s rRNA (ibosomal RNA) of the sequence number 1. The Nocardia sp. CS682 or fermentation culture liquid containing the nargenicin produced from the strain is used as an animal feed additive or promoting agent of animal growth.
Abstract translation: 提供了一种能产生对耐甲氧西林金黄色葡萄球菌（MRSA）具有优异抗菌活性的化学物质的新型微生物，以提高具有高抗菌活性的动物饲料的效率，并用作饲料添加剂。 诺卡氏菌 CS682（KCTC 11297BP）从土壤中分离。 诺卡氏菌 CS682（KCTC 11297BP）具有序列1的16s rRNA（异型RNA）。诺卡氏菌属 CS682或含有由该菌株产生的Nargenicin的发酵培养液用作动物饲料添加剂或动物生长促进剂。
-
公开(公告)号：KR1020110049967A
公开(公告)日：2011-05-13
申请号：KR1020090106758
申请日：2009-11-06
Applicant: 조선대학교산학협력단
IPC: A61K36/258 , A61P35/02 , A61K31/203 , A61K31/59
CPC classification number: A61K36/258 , A61K2236/33 , Y10S514/908
Abstract: PURPOSE: An anticancer drug composition containing ginseng extract is provided to differenetiate undifferentiated promyelocytic blood cells and to be used as a therapeutic agent for promyelocytic leukemia. CONSTITUTION: An anticancer composition contains methanol extract of ginseng, 1,25-dihydroxy vitamin D_3(1,25-(OH)_2D_3) or all-transfretinoic acid mixture and carrier. A therapeutic agent for promyeolocytic leukemia contains the ginseng methanol extract as an active ingredient and pharmaceutically acceptable carrier. The final concentration of 1,25-(OH)_2D_3, retinoic acid, and nargenicin is 5 nM, 50 nM, and 200 mM, respectively.
Abstract translation: 目的：提供含有人参提取物的抗癌药物组合物，以分化未分化的前髓细胞血细胞，并用作早幼粒细胞白血病的治疗剂。 构成：抗癌组合物含有人参甲醇提取物，1,25-二羟基维生素D_3（1,25-（OH）_2D_3）或全转氨酸的混合物和载体。 前列腺细胞性白血病的治疗剂含有人参甲醇提取物作为活性成分和药学上可接受的载体。 1,25-（OH）_2D_3，视黄酸和Nargenicin的最终浓度分别为5nM，50nM和200mM。
-
公开(公告)号：KR101040468B1
公开(公告)日：2011-06-09
申请号：KR1020080043926
申请日：2008-05-13
Applicant: 조선대학교산학협력단
Abstract: 본 발명은 메티실린 내성 포도상구균 균주에 탁월한 항균 활성을 나타내는 화학물질을 생산하는 새로운 미생물 균주 및 이 균주에서 생산되는 항균 활성 물질을 함유하고 있는 배양액에 관한 것이다. 본 발명의 신규 미생물 및 이로부터 생산되는 항균활성 물질을 포함하는 배양액은 기존 항생제의 계속되는 사용으로 인한 메티실린 내성 균주의 내성화 문제의 해결에 활용될 수 있다. 특히 본 배양액은 동물사료용 항생제를 대체 할 수 있으며 동물성장을 촉진하고 사료효율을 개선시키는 사료첨가제 성분으로 효과적으로 사용될 수 있다.
나르제니신, 사료첨가제-
公开(公告)号：KR100807196B1
公开(公告)日：2008-02-28
申请号：KR1020060128398
申请日：2006-12-15
Applicant: 조선대학교산학협력단
IPC: A61K35/618 , A61K9/00
CPC classification number: A61K35/618 , A61K9/0053
Abstract: An extract of Scapharca broughtonii is provided to be able to inhibit the induction of promyelocytic leukemia and auto-immune diseases, thereby being widely utilized as an anti-cancer agent or for treating various immune-diseases. A pharmaceutical composition for treating promyelocytic leukemia comprises an alcohol extract of Scapharca broughtonii and a pharmaceutically acceptable carrier. A method for preparing an alcohol fraction of the Scapharca broughtonii comprises the steps of: (a) after removing muscle from the Scapharca broughtonii and washing it with ice-cooled salt, freeze-drying it; (b) after finely cutting the frozen muscle and dipping it in a mixture solvent of ethanol and water in a volumetric ratio of 60:40 at room temperature of 3-10 days, evaporating an ethanol-aqueous solution obtained by removing remaining solid phase materials therefrom through centrifugation under reduced pressure to eliminate the ethanol; (c) adding activated carbon to the aqueous solution and agitating it; (d) separating the activated carbon from the aqueous solution through filtration and washing it with distilled water; (e) respectively eluting effective ingredients from the activated carbon using an 80% aqueous solution of acetone and 100% ethanol; (f) putting two eluents together and drying it under reduced pressure; (g) subjecting the dried material to a stepwise elution using 100% ethyl acetate, 100% ethanol and 100% methanol to fractionate; and (h) respectively concentrating the obtained ethanol fraction and methanol fraction and respectively purifying them through a silica-gel chromatography.
Abstract translation: 提供石斛提取物以能够抑制早幼粒细胞白血病和自身免疫疾病的诱导，从而被广泛用作抗癌剂或用于治疗各种免疫疾病。 一种用于治疗早幼粒细胞白血病的药物组合物，其包含石菖蒲的酒精提取物和药学上可接受的载体。 用于制备石菖蒲酒精馏分的方法包括以下步骤：（a）从玻璃after after中除去肌肉后，用冰冷却的盐洗涤，冷冻干燥; （b）精细切割冷冻肌肉后，在3-10天的室温下将体积比为60:40的乙醇和水的混合溶剂浸渍，蒸发除去剩余的固相物质得到的乙醇 - 水溶液 通过在减压下离心以除去乙醇; （c）向水溶液中加入活性炭并搅拌; （d）通过过滤从水溶液中分离活性炭并用蒸馏水洗涤; （e）使用80％丙酮和100％乙醇水溶液分别从活性炭洗脱有效成分; （f）将两种洗脱液放在一起，减压干燥; （g）使用100％乙酸乙酯，100％乙醇和100％甲醇对干燥的物质进行逐步洗脱以分馏; 和（h）分别浓缩得到的乙醇级分和甲醇级分，并通过硅胶色谱法分别纯化。
-
-
-
-
-
-
-
-
-
Search Results
11
records
(took 0.023 seconds)
